Advanced Net Receivables from 2010 to 2024

AMS Stock   197.40  1.40  0.71%   
Advanced Medical's Net Receivables is increasing over the years with slightly volatile fluctuation. Net Receivables is expected to dwindle to about 12.8 M. During the period from 2010 to 2024 Advanced Medical Net Receivables annual values regression line had geometric mean of  10,978,508 and mean square error of 26.4 T. View All Fundamentals
 
Net Receivables  
First Reported
2004-06-30
Previous Quarter
20.9 M
Current Value
29 M
Quarterly Volatility
6.5 M
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Advanced Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Advanced Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.3 M, Interest Expense of 250.6 K or Total Revenue of 132.5 M, as well as many indicators such as . Advanced financial statements analysis is a perfect complement when working with Advanced Medical Valuation or Volatility modules.
  
This module can also supplement various Advanced Medical Technical models . Check out the analysis of Advanced Medical Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Advanced Stock

Advanced Medical financial ratios help investors to determine whether Advanced Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Advanced with respect to the benefits of owning Advanced Medical security.